| Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson’s disease S Kim, SH Kwon, TI Kam, N Panicker, SS Karuppagounder, S Lee, JH Lee, ... Neuron 103 (4), 627-641. e7, 2019 | 1029 | 2019 |
| Chemogenetics revealed: DREADD occupancy and activation via converted clozapine JL Gomez, J Bonaventura, W Lesniak, WB Mathews, P Sysa-Shah, ... Science 357 (6350), 503-507, 2017 | 962 | 2017 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 803 | 2020 |
| Autoimmune hypophysitis P Caturegli, C Newschaffer, A Olivi, MG Pomper, PC Burger, NR Rose Endocrine reviews 26 (5), 599-614, 2005 | 766 | 2005 |
| State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines CM Dawidczyk, C Kim, JH Park, LM Russell, KH Lee, MG Pomper, ... Journal of Controlled Release 187, 133-144, 2014 | 586 | 2014 |
| Diffusion tensor MR imaging of the brain and white matter tractography ER Melhem, S Mori, G Mukundan, MA Kraut, MG Pomper, PCM van Zijl American Journal of Roentgenology 178 (1), 3-16, 2002 | 534 | 2002 |
| Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer Z Szabo, E Mena, SP Rowe, D Plyku, R Nidal, MA Eisenberger, ... Molecular imaging and biology 17, 565-574, 2015 | 488 | 2015 |
| Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP YH Ko, BL Smith, Y Wang, MG Pomper, DA Rini, MS Torbenson, ... Biochemical and biophysical research communications 324 (1), 269-275, 2004 | 462 | 2004 |
| 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate … Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ... Clinical cancer research 17 (24), 7645-7653, 2011 | 412 | 2011 |
| Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer SM Hillier, KP Maresca, FJ Femia, JC Marquis, CA Foss, N Nguyen, ... Cancer research 69 (17), 6932-6940, 2009 | 411 | 2009 |
| Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging J Zhou, JO Blakeley, J Hua, M Kim, J Laterra, MG Pomper, PCM Van Zijl Magnetic Resonance in Medicine: An Official Journal of the International …, 2008 | 405 | 2008 |
| Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging S Mori, K Frederiksen, PCM Van Zijl, B Stieltjes, MA Kraut, M Solaiyappan, ... Annals of Neurology: Official Journal of the American Neurological …, 2002 | 393 | 2002 |
| Amide proton transfer imaging of human brain tumors at 3T CK Jones, MJ Schlosser, PCM Van Zijl, MG Pomper, X Golay, J Zhou Magnetic Resonance in Medicine: An Official Journal of the International …, 2006 | 385 | 2006 |
| Routine clinical brain MRI sequences for use at 3.0 Tesla H Lu, LM Nagae‐Poetscher, X Golay, D Lin, M Pomper, PCM Van Zijl Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2005 | 379 | 2005 |
| Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer CA Foss, RC Mease, H Fan, Y Wang, HT Ravert, RF Dannals, ... Clinical cancer research 11 (11), 4022-4028, 2005 | 361 | 2005 |
| Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner Y Wang, J Seidel, BMW Tsui, JJ Vaquero, MG Pomper Journal of Nuclear Medicine 47 (11), 1891-1900, 2006 | 357 | 2006 |
| Tissue Sodium Concentration in Human Brain Tumors as Measured with 23Na MR Imaging1 R Ouwerkerk, KB Bleich, JS Gillen, MG Pomper, PA Bottomley Radiology 227 (2), 529-537, 2003 | 346 | 2003 |
| Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) SR Banerjee, CA Foss, M Castanares, RC Mease, Y Byun, JJ Fox, ... Journal of medicinal chemistry 51 (15), 4504-4517, 2008 | 332 | 2008 |
| Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic … SY Cho, KL Gage, RC Mease, S Senthamizhchelvan, DP Holt, ... Journal of Nuclear Medicine 53 (12), 1883-1891, 2012 | 329 | 2012 |
| NAAG peptidase inhibitors and their potential for diagnosis and therapy J Zhou, JH Neale, MG Pomper, AP Kozikowski Nature reviews Drug discovery 4 (12), 1015-1026, 2005 | 323 | 2005 |
